Offering Integrated Care for HIV/AIDS, Diabetes and Hypertension within Chronic Disease Clinics in Cambodia. by Janssens, B et al.
880 Bulletin of the World Health Organization | November 2007, 85 (11)
Introduction
At the end of 2004, there were an esti-
mated 100 000 people living with HIV/ 
AIDS in Cambodia, of whom ap-
proximately 25 000 were estimated to 
urgently require care and treatment 
with highly active antiretroviral therapy 
(HAART).1,2
Cambodia is struggling with a grow-
ing burden of chronic diseases. A survey 
done in 2005 estimated that between 
5% and 11% of all adults had type II 
diabetes and the prevalence of impaired 
glucose intolerance was between 10% 
and 15%. The same survey showed that 
between 12% and 25% of the popula-
tion screened could be classified as being 
hypertensive.3 These results are consis-
tent with growing evidence that diabetes 
and other non-communicable diseases 
represent a significant and growing part 
of the disease burden in low-income 
countries.4,5
Problem In Cambodia, care for people with HIV/AIDS (prevalence 1.9%) is expanding, but care for people with type II diabetes 
(prevalence 5–10%), arterial hypertension and other treatable chronic diseases remains very limited.
Approach We describe the experience and outcomes of offering integrated care for HIV/AIDS, diabetes and hypertension within 
the setting of chronic disease clinics.
Local setting Chronic disease clinics were set up in the provincial referral hospitals of Siem Reap and Takeo, 2 provincial capitals 
in Cambodia.
Relevant changes At 24 months of care, 87.7% of all HIV/AIDS patients were alive and in active follow–up. For diabetes patients, 
this proportion was 71%. Of the HIV/AIDS patients, 9.3% had died and 3% were lost to follow-up, while for diabetes this included 
3 (0.1%) deaths and 28.9% lost to follow-up. Of all diabetes patients who stayed more than 3 months in the cohort, 90% were 
still in follow-up at 24 months.
Lessons learned Over the first three years, the chronic disease clinics have demonstrated the feasibility of integrating care for 
HIV/AIDS with non-communicable chronic diseases in Cambodia. Adherence support strategies proved to be complementary, 
resulting in good outcomes. Services were well accepted by patients, and this has had a positive effect on HIV/AIDS-related stigma. 
This experience shows how care for HIV/AIDS patients can act as an impetus to tackle other common chronic diseases.
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In 2002, Médecins Sans Frontières 
(MSF) and the Cambodian Ministry 
of Health established chronic disease 
clinics to integrate HIV/AIDS care 
with the management of diabetes and 
hypertension in two provincial capitals, 
Takeo and Siem Reap. This paper de-
scribes the approach and outcomes of 
this strategy.
Context
Siem Reap and Takeo are both predomi-
nantly rural provinces, although the 
urban population of Siem Reap town 
is increasing rapidly due to growing 
tourism around the Angkor Wat temple 
complex. Both locations were selected 
for this pilot programme because they 
are large provincial centres with referral 
hospital capacity to expand activities. 
Furthermore, adequate care for the tar-
get diseases at these sites was lacking.
HAART began to be provided 
in Cambodia in 2001. By the end of 
2005, 12 355 people were on treatment 
through programmes run jointly by the 
Ministry of Health and nongovernmen-
tal organizations (NGOs).
Chronic diseases are largely ne-
glected in developing countries.6 In 
Cambodia, medical care for diseases 
such as diabetes, arterial hypertension 
and epilepsy was not generally included 
in the reconstruction of the health care 
system over the past 15 years. Most dia-
betics receive only limited medication 
at referral hospital outpatient depart-
ments or when they arrive with severe 
hyperglycaemia at emergency wards; 
they are rarely referred to long-term care 
once they are discharged. Some drugs 
to treat arterial hypertension are avail-
able at hospitals and health centres, but 
these are usually provided for only two 
weeks.
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Rationale for the chronic disease 
clinics
The rationale to combine care of HIV/
AIDS, diabetes and hypertension was 
based on three assumptions.
First, the availability of antiretrovi-
ral treatment in developing countries is 
transforming HIV/AIDS into a chronic 
disease, as has been the experience else-
where.7 It was anticipated that in this 
resource-poor context, efficiency gains 
could be attained through the estab-
lishment of a multidisciplinary chronic 
disease care team that would use a com-
mon approach to respond to the needs 
of chronic disease patients, especially in 
providing continuity of care, long-term 
adherence support and social support.
Second, in Cambodian society as 
elsewhere, the stigma attached to HIV/
AIDS presents a barrier to care. By pro-
viding care for seropositive clients and 
patients with other chronic diseases 
within the same facility, it was hoped 
that facility-related stigma could be 
reduced.
Third, it was considered important 
that the care delivery model should re-
flect epidemiological realities. Although 
at the clinics’ inception reliable epide-
miological data on diabetes and other 
chronic diseases was lacking, these ill-
nesses were recognized to contribute 
an increasing share of the total burden 
of disease in Cambodia. Diabetes was 
given a specific priority, since it was seen 
by many health workers as a frequent 
problem. The provision of systematic 
and continuous care for chronic diseases 
was encouraged by both the Ministry of 
Health and local WHO representatives, 
who were involved in the final design of 
this pilot health care delivery model.
Development of services
As in the rest of the country’s public 
hospitals, no structured care for HIV 
or diabetes existed before the chronic 
disease programmes. These began with 
a strong emphasis on outpatient consul-
tations, with services actively promoted 
as clinics for treatment of diabetes, hy-
pertension and HIV/AIDS. Regarding 
other chronic diseases, mental health 
patients were not included, as mental 
health clinics existed in both provinces, 
while some other patients, such as epi-
leptics and those with thyroid disorders, 
were accepted but were few in number.
All consultations were carried out 
by doctors who received training on the 
principles of chronic disease manage-
ment and a patient-centred approach. 
Counsellors were also recruited, al-
though when the clinics started counsel-
lors were not yet a recognized part of the 
Cambodian health system and trained 
psychologists were and still are rare. 
Counsellors were either nurses or staff 
members recruited after an evaluation of 
appropriate personal skills. A continu-
ous training programme was organized 
by MSF for all staff to deal with newly 
appearing needs and problems, and to 
introduce new tools and guidelines. 
Most of the training was organized as 
on-the-job training, with theoretical 
training sessions organized around spe-
cific topics every three months.
The complex needs of chronic pa-
tients relied on a functional collabora-
tion with several other hospital depart-
ments, particularly for severely ill AIDS 
patients. A separate infectious diseases 
inpatient ward with appropriate staff 
resources and equipment was set up 
in each hospital. Efforts were made to 
integrate services for tuberculosis and 
HIV for efficient care of co-infected 
patients.
Staffing in both clinics was gradu-
ally increased to meet the increasing 
patient load, from 8 staff members in 
2003 to a total of 20 full-time staff 
members (8 medical doctors, 8 counsel-
lors and 4 nurses) in 2005. Of this total, 
10 were engaged from other hospital 
departments, and the rest were engaged 
with MSF funds. MSF also provided 
financial support for the new clinic func-
tions, mainly the purchase of medicines 
that were not routinely available from 
the Ministry of Health (initially includ-
ing antiretrovirals and all medicines for 
opportunistic infections) and incentives 
for staff members who had to cope with 
ever-increasing workloads. Investments 
were also made to improve the struc-
tures and medical equipment of the 
clinics, hospitals and laboratories. All 
operating costs – medicines and staff 
salaries – were gradually taken over by 
the Ministry of Health.
Description of services
Every new patient was given a unique 
identification code and an individual 
medical file. All HIV services were 
provided free of charge according to 
national policy. Diabetes patients pay 
a fixed fee per consultation of approxi-
mately US$ 0.50, which also covers 
the costs of drugs and diagnostics. For 
diabetics and other patients, a routine 
questionnaire is used to assess income 
and eligibility for exemption from these 
user fees.
All new HIV/AIDS patients were 
staged at their first visits by WHO clini-
cal staging and a CD4 count. Treatment 
for opportunistic infections, mainly 
tuberculosis and cryptococcus menin-
gitis, was provided where needed and 
prophylaxis for PCP (cotrimoxazole) 
and cryptococcal meningitis (flucon-
azol) was started according to national 
guidelines. For all patients requiring 
antiretroviral treatment (CD4 count 
< 200 cells/mm³ or WHO stage IV), a 
standardized medical and psychosocial 
treatment preparedness plan was fol-
lowed. Almost all patients were started 
on a standard first-line regimen of 
stavudine, lamivudine and nevirapine; 
zidovudine and efavirenz were used as 
alternatives in case of intolerance to the 
first-line regimen. Most regimens were 
given as generic fixed-dose combina-
tions. Once on HAART, patients were 
followed up on a monthly basis and a 
routine laboratory protocol of alanine 
aminotransferase, and haemoglobin at 
months 1, 2, 3, 6 and 12 was used to 
monitor for drug side-effects. Treatment 
success was monitored by CD4 lympho-
cyte count every 6 months.
Diabetes patients were all type 2 
and treatment was based on two oral 
hypoglycaemic drugs: metformin and 
glibenclamide. For a limited number of 
patients insulin therapy was commenced 
using slow-release insulin (Insulatard, 
Novo Nordisk, Denmark) at two doses 
every 24 hours. Priority was given to 
the stabilization of blood glucose levels, 
control of blood pressure and diagnosis 
and care of foot sores. Prior to 2006, 
routine monitoring of glycosolated hae-
moglobin (HbA1c) was not possible due 
to high cost, but this has since become a 
routine monitoring test.
Patients with arterial hypertension 
were treated according to a protocol 
based on standard guidelines, using a 
stepwise approach with hydrochloro-
thiazide, atenolol and captopril as the 
main antihypertensive drugs. The objec-
tive was to control arterial blood pres-
sure below 160/90 mmHg.
In both clinics, a team of coun-
sellors provided a series of activities 
complementary to the medical con-
sultations, for both HIV/AIDS and 
diabetes patients. The principal objec-
tive of the counselling activities was to 
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encourage drug adherence and lifestyle 
changes with information and psycho-
social support, with the long-term aim 
of providing patients with the means 
(knowledge and confidence) to assume 
more responsibility in the management 
of their disease.8 Peer-support groups 
were established for antiretroviral users 
and diabetics; these groups provide an 
essential continuation of the work of the 
counsellors and doctors.
Patients and outcomes
Data on patient history and progression 
on treatment were obtained at every 
consultation. For HIV patients, data 
were entered into routine monitoring 
software (Fuchia, Epicentre, Paris); for 
other chronic disease patients, a tailored 
database was established.
Between March 2002 and Decem-
ber 2005, a total of 9149 chronic disease 
patients attended one of the clinics at 
least once (5273 in Siem Reap and 3876 
in Takeo); 4793 of these were HIV-
positive, 2638 had diabetes, 1419 were 
hypertensive and 299 were diagnosed 
with another chronic disease.
Among HIV patients, median CD4 
at baseline was 53 cells/mm³; 72% were 
in need of HAART at first consultation 
and a total of 2497 people living with 
HIV/AIDS started HAART. Among 
diabetics, doctors registered one or more 
complications (peripheral neuropathy, 
nephropathy, retinopathy or coronary 
heart disease) in 15.2% of these pa-
tients. In both centres, new diabetic pa-
tients outnumbered new HIV patients 
(Fig. 1) during the programme’s early 
months. Towards the end of the third 
quarter, the number of new HIV/AIDS 
patients exceeded the number of new 
diabetes patients and continued to in-
crease in both centres, while the num-
ber of new diabetics remained stable at 
an average of 52 patients per month in 
both clinics combined.
A cohort analysis of all patients at 
24 months of treatment shows that 87.7% 
of HIV patients who started HAART and 
71% of the diabetics were still alive and 
in active follow-up (Table 1). Only 3% 
of HIV patients on HAART were lost to 
follow-up; 9.3% had died, with mortality 
highest in the first 3 months, reflecting 
the fact that most patients sought care 
at a very late stage in their disease. In 
contrast, of the 29% losses in the diabetes 
cohort, only 3 (0.1%) patients had died, 
and the rest were lost to follow–up, with 
64% lost to follow-up in the first three 
months. Of the patients who remained in 
care at 3 months, 90% were still in care 
Fig. 1. Inflow of new patients in chronic disease clinics, Cambodia
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at 24 months or more. In the cohort of 
hypertension patients, 32% were lost to 
follow-up. Here again, most of the pa-
tients who discontinued care did so early 
in treatment. Of all patients who stayed 
longer than two months in follow-up, 
81% were still in regular follow-up at 
12 months.
The median CD4 count of HIV 
patients on HAART rose from 53 cells/
mm³ at baseline to 218 cells/mm³ at 
month 12 and 316 cells/ mm³ at month 
24 of treatment. Between June 2006 and 
February 2007, HbA1c results became 
available for 451 diabetes patients with 
more than 6 months of regular treat-
ment, which is 27% of the active cohort. 
The median value was 8.6%; 57% of the 
patients had an HbA1c below or equal 
to 9%. Of all hypertension patients who 
were on regular drug therapy for more 
than 6 months in December 2006, 68% 
had reached blood pressures equal to or 
below the target of 160/90 mmHg.
Table 1. Survival and cohort retention of HIV/AIDS patients who started HAART and diabetes patients who started treatment 
in chronic disease clinics, Takeo and Siem Reap
Months on treatment 0–3 3–6 6–12 12–18 12–24 24+
HIV patients
N 2 497a 2 317 1 906 1 288 691 300 289
Deaths (cumulative) 110 37 (147) 34 (181) 16 (197) 4 (201) 0 (201)
Lost to follow-up (cumulative) 36 19 (55) 15 (70) 7 (77) 1 (78) 2 (80)
Transfer out to other service (cumulative) 25 48 (73) 80 (153) 58 (211) 13 (224) 3 (227)
Median CD4 count (cells/mm³) 53 154 180 218 269 309 344
% remaining in careb 94.1 91.7 89.3 88 87.7 87.6
Diabetes patients
N 2 638a 2 484 1 795 1 321 801 457 25
Deaths (cumulative) 0 0 2 0 0 1 (3)
Lost to follow-up (cumulative) 487 91 (578) 116 (694) 52 (746) 15 (761) 9 (770)
Transfer out to other service (cumulative) 1 0 1 1 0 0
% remaining in careb 81.5 78.1 73.6 71.6 71 70.7
a  All patients who started HAART or diabetes treatment in the chronic disease clinics of Siem Reap or Takeo.
b  Kaplan–Meier survival estimate.
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Résumé
Offre de soins intégrée à l’intention des personnes vivant avec le VIH/sida, un diabète ou de l’hypertension 
par les dispensaires cambodgiens spécialisés dans les maladies chroniques
Problématique Au Cambodge, l’offre de soins à l’intention des 
personnes vivant avec le VIH/sida (prévalence : 1,9 %) est en 
développement, mais pour les personnes atteintes de diabètes 
de type II (prévalence 5 à 10 %), d’une hypertension artérielle 
ou d’une autre maladie chronique pouvant être traitée, elle reste 
très limitée.
Démarche Nous décrivons l’expérience et les résultats obtenus 
avec une offre de soins intégrée à l’intention des personnes vivant 
avec le VIH/sida, un diabète ou une hypertension, dans le cadre 
de dispensaires spécialisés dans les maladies chroniques.
Contexte local Des dispensaires spécialisés dans les maladies 
chroniques ont été mis en place dans les hôpitaux spécialisés de 
Siem Reap et Takeo, deux capitales provinciales du Cambodge.
Modifications pertinentes Au bout de 24 mois de soins, sur 
l’ensemble des patients vivant avec le VIH/sida, 87,7 % étaient 
encore vivants et faisaient l’objet d’un suivi actif. S’agissant des 
patients diabétiques, cette proportion était de 71 %. Parmi les 
patients contaminés par le VIH, 9,3 % étaient morts et 3 % 
étaient perdus de vue, tandis que parmi les diabétiques, on 
enregistrait 3 décès (0,1 %) et une proportion de 28,9 % de 
perdus de vue. Parmi l’ensemble des patients diabétiques restés 
plus de 3 mois dans la cohorte, 90 % étaient encore suivis au 
bout de 24 mois.
Enseignements tirés Sur les trois premières années, les 
dispensaires spécialisés dans les maladies chroniques ont prouvé 
la faisabilité d’une offre de soins intégrée pour les personnes 
Discussion
The experience of these two chronic 
diseases in Cambodia shows that inte-
grating care for HIV/AIDS with care for 
other chronic diseases is feasible, result-
ing in satisfactory outcomes for patients 
and efficiency gains for the services.
Over three years, the two centres 
demonstrated that staff could effectively 
assume a multidisciplinary role and that 
skills to manage patients who need to 
start a lifelong treatment were relevant 
to and effective for both HIV/AIDS 
and diabetic care. Doctors adapted to 
the role of chronic diseases specialists 
and gradually adopted a patient-centred 
approach. Adherence support counsel-
lors, a new function in the health-care 
system that was created with expanding 
HIV/AIDS care, have been shown to be 
valuable in supporting adherence and 
lifestyle changes for diabetics.
The rapid expansion of patient 
inflow is a good indicator that these 
services were well accepted by both 
diabetics and HIV patients. The latter 
arrived in very small numbers in the 
first months after the clinics opened 
but numbers increased significantly 
after this initial period. We believe this 
is partly because they could mingle with 
other patients with less stigma-associated 
diseases. Nevertheless, the high early 
mortality and low median CD4 reflects 
the fact that large number of patients 
had no access to HAART earlier. The 
fact that the inflow of new diabetes 
patients never slowed, even with clinic 
waiting rooms often crowded with very 
ill HIV patients, is another indicator 
that the services were well accepted.
At 24 months on HAART, only 
3% of HIV patients were lost to care, 
while this was true for almost 30% for 
the diabetics. A more detailed analysis 
of the diabetic cohort shows that most 
of the losses to follow-up appear in the 
first 3 months; after that, almost 90% 
of diabetics remained part of the cohort 
at 24 months of follow-up. Many rea-
sons could explain the early dropouts: 
diabetes is not seen as life-threatening, 
alternative care through private provid-
ers exists and some patients might be 
uncomfortable sharing premises with 
HIV patients. This needs to be evalu-
ated more fully.
Outcomes of patients who started 
HAART compare favourably or equally 
to other described cohorts, both in 
western settings and in other developing 
countries.9,10 The results of the diabetes 
patients are measured by HbA1c, and 
at this stage the interpretation of these 
results is limited because no baseline 
values are available for the patients of 
the diabetic cohort; results are only avail-
able for 27% of all patients and these do 
not represent a randomized sample. The 
mean HbA1c value measured is 0.7% 
higher than was found in a 24-month 
western cohort;11 no comparable data 
from a resource-limited context were 
found in the literature.
Attention to diabetes care at the 
Cambodian health ministry is still lim-
ited, reflecting scarce funding for non-
communicable disease control. This 
has clearly limited the extent to which 
these programmes could be replicated, 
although gradually more stakeholders, 
like the ministry’s newly established 
non-communicable diseases working 
group, see the added value of this model 
of care.
The burden of chronic diseases 
in developing countries has received 
increasing attention recently. WHO 
has called for innovative action in this 
regard,12 and it has been argued that 
NGOs should address these huge un-
met needs13 and that chronic diseases 
should figure more prominently on the 
international development agenda.14
The justifiable increase in atten-
tion to HIV/AIDS in recent years has 
highlighted the fact that other chronic 
diseases remain neglected. The chronic 
disease clinics approach has demon-
strated an ability to respond to these 
epidemiological realities, and provides 
an example of how the considerable 
attention to and funding of HIV/AIDS 
care can offer an opportunity to im-
prove care for non-communicable dis-
eases like diabetes and hypertension, 
which are increasingly seen as high-
priority public health challenges for the 
developing world.15
Now that HAART is becoming 
progressively more available in the de-
veloping world, HIV care is a matter 
of chronic disease management. There 
is an important opportunity for HIV 
programmes to both learn from and 
reinforce other chronic disease pro-
grammes. In Cambodia, the experience 
of the chronic disease clinics has shown 
that care can be integrated. Because staff 
and services are complementary, patient 
outcomes are good and there are indica-
tions that the integration has reduced 
HIV-related stigma.  ■
Competing interests: None declared.
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vivant avec le VIH/sida et atteintes d’une maladie chronique non 
transmissible au Cambodge. La complémentarité des stratégies 
d’aide à l’observance a également été démontrée, d’où l’obtention 
de bons résultats. Ces services sont bien acceptés par ces patients, 
ce qui a un effet positif sur la stigmatisation dont ils souffrent. Cette 
expérience montre à quel point la prise en charge des personnes 
vivant avec le VIH/sida peuvent donner une impulsion à celle 
d’autres maladies chroniques courantes.
Problema En Camboya se está extendiendo masivamente la 
atención a las personas con infección por VIH/SIDA (prevalencia 
del 1,9%), pero la atención a las personas con diabetes de 
tipo 2 (prevalencia: 5%–10%), hipertensión arterial y otras 
enfermedades crónicas tratables sigue siendo muy limitada.
Enfoque Describimos la experiencia y los resultados de la 
oferta de atención integrada para la infección por VIH/SIDA, la 
diabetes y la hipertensión en el entorno de los dispensarios de 
enfermedades crónicas.
Contexto local Se establecieron dispensarios de enfermedades 
crónicas en los hospitales de referencia provinciales de Siem Reap 
y Takeo, dos capitales de provincia de Camboya.
Cambios destacables Tras 24 meses de aplicación de ese 
régimen de atención, el 87,7% de todos los pacientes con VIH/
SIDA permanecían con vida y sometidos a seguimiento activo. 
Entre los pacientes con diabetes esa proporción era del 71%. 
De los pacientes con VIH/SIDA, el 9,3% habían muerto y un 3% 
Resumen
Atención integrada contra el VIH/SIDA, la diabetes y la hipertensión en dispensarios de enfermedades 
crónicas de Camboya
se habían perdido en el seguimiento, mientras que las cifras 
para la diabetes fueron de 3 (0,1%) defunciones y un 28,9% 
perdidos en el seguimiento. De todos los pacientes con diabetes 
que permanecieron más de 3 meses en la cohorte, el 90% se 
encontraban aún sometidos a seguimiento a los 24 meses.
Enseñanzas extraídas Durante los tres primeros años, los 
dispensarios de enfermedades crónicas han demostrado la 
viabilidad de la integración de la atención contra el VIH/SIDA y la 
proporcionada contra las enfermedades crónicas no transmisibles 
en Camboya. Las estrategias de apoyo a la observancia tuvieron 
un efecto complementario, lo que se tradujo en buenos resultados. 
Los servicios fueron bien aceptados por los pacientes, y eso tuvo 
un efecto positivo en la estigmatización relacionada con el VIH/
SIDA. Esta experiencia demuestra que la atención a los pacientes 
con VIH/SIDA puede ser un estímulo para hacer frente a otras 
enfermedades crónicas comunes.
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صخلم
مدلا طغض عافتراو ير َّكسلاو هسويرفب ىودعلاو زديلإل ةلماكتلما ةياعرلا ءاتيإ
ايدوبمك في ةنمزلما ضارملأا تادايع نمض
 وأ زديلإاب ينباصملل ايدوبمك في م َّدقت يتلا ةياعرلا قاطن عسَّتي :ةلكشلما
 ةدودحم لازتلا ةياعرلا نأ لاإ ،)%1.9 هراشتنا لدعمو( هسويرفب ىودعلاب
 عافتراو ،)%10-5 هراشتنا لدعمو( ير َّكسلا نم نياثلا طمنلا ضىرلم ًادج
.ةجلاعلماب أبرت يتلا ةنمزلما ضارملأا نم كلذ يرغو مدلا طغض
 ةياعرلا ءاتيإ نع جتنت يتلا لئاصحلاو تابرخلل ًافصو نوثحابلا م َّدق :بولسلأا
 قفارم نمض مدلا طغض عافتراو ير َّكسلاو هسويرفب ىودعلاو زديلإل ةلماكتلما
.ةنمزلما ضارملأا تادايع
 في ةلاحلإا تايفشتسم في ةنمزلما ضارملأا تادايع ت َّسـسأ دقل :ليحلما قفرلما
. ْنينَتَّيدوبمك ْنينَتيلاول ناتمصاع ماهو ،ويكاتو بير ميس ْنيَتيلاو
 لمجم نم %87.7 ناك ةياعرلا ي ِّقلت نم ًارهش 24 دعب :ةلصلا تاذ تا ُّريرغتلا
 امأ .ةلا َّعف ةعباتلم نوعضخيو ةايحلا ديق لىع هسويرفب ىودعلاو زديلإا ضىرم
 ينب نمو ،%71 ةايحلا ديق لىع مهنم يقب نم ناك دقف ينـيركسلل ةبسنلاب
 ةعباتم  تدقُف  مايف  مهنم  %9.3  تام  هسويرفب  ىودعلاو  زديلإاب  ينباصلما
 ينب نمو .مهنم %28.9 ةعباتم تدقفو )%1( 3 تام ينـيركسلا نمو ،%3
 لظ ،بارتلأا  نمض روهش 3  لىع ديزت  ةدلم  اوقب  نيذلا  ينـيركسلا  عيمج
.ًارهش 24 ىتح ةعباتلما نوقلتي %90
 ضارملأا  ةدايع  تتبثأ  ،لىولأا  ةثلاثلا  تاونسلا  للاخ  :ةدافتسلما  سوردلا
 ضارملأا نمض هسويرفب ىودعلاو زديلإا ضرم ةياعر جامدإ ةيناكمإ ةنمزلما
 اهنأ لاثتملاا معد ةيجيتارـتسا تتبثأ دقو .ايدوبمك في ةيراسلا يرغ ةنمزلما
 ،ضىرلما ىدل ًادج ةلوبقم تامدخلا تناك دقو .ةديج لئاصح تاذو ،ةل ِّمكم
 ضربم ةباصلإا نع ةمجانلا ةمصولاب قلعتي ام في ةيباجيإ تايرثأت ىطعأ مام
 ةم َّدقلما ةياعرلل نكيم فيك ةبرجتلا هذه رهظتو .هسويرفب ىودعلاو زديلإا
 ىرخأ ةنمزم ضارمأ ةجلاعلم ًاعفاد نوكت نأ هسويرفب ىودعلاو زديلإا ضىرلم
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